Aura Biosciences, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2021 | $-5.1M | $-5.2M | $71.0K | $185.0K |
| Mar 2022 | $-15.2M | $-15.8M | $599.0K | $1.6M |
| Mar 2023 | $-16.4M | $-16.5M | $109.0K | $1.9M |
| Mar 2024 | $-24.5M | $-24.5M | $88.0K | $2.9M |
| Mar 2025 | $-23.4M | $-23.5M | $187.0K | $3.5M |
| Mar 2026 | $-29.9M | $-30.0M | $102.0K | $3.8M |